Diversify your portfolio with some of Britain's most established companies. Our analysts have carefully selected these UK powerhouses that span multiple industries from banking to pharmaceuticals, energy to consumer goods.
These UK giants have worldwide reach and operations. Companies like HSBC, Shell, and AstraZeneca are household names globally, letting you tap into international markets through British expertise.
Many British companies have long histories of paying consistent dividends. Stocks like British American Tobacco and Diageo are known for rewarding shareholders with regular income alongside potential growth.
The UK is home to 17 companies on the Fortune Global 500 list. Investing in these market leaders means owning a piece of businesses that shape entire industries and economies worldwide.
The UK represents the world's sixth-largest economy with London as a leading financial hub. These stocks offer a strategic mix of defensive and cyclical investments across diverse sectors like pharmaceuticals, energy, finance, and consumer goods, providing both stability and growth potential.
This collection features multinational corporations with global presence and influence, underpinned by the UK's strong regulatory framework. Many of these companies offer consistent dividends and represent traditional strength combined with innovative approaches to changing markets.
These companies were selected for their market leadership, proven resilience, and international reach. From pharmaceutical giant AstraZeneca to energy leaders Shell and BP, these stocks represent Britain's economic strength while offering exposure to various sectors of the global economy.
Market capitalisation breakdown for 'Made in the UK' basket
AZN: $258.54B
HSBC: $226.47B
GSK: $89.36B
Erfahren Sie alles über diesen Aktienkorb. Lesen Sie unseren ausführlichen Artikel zu seinen Risiken und seinem Potenzial.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+4
Here are a few of the assets in this group. Create an account to unlock the full list.
Unlock all stocks by downloading the app for FREE.
Es dauert nur 60 Sekunden.
Analysten erwarten im Durchschnitt, dass die Werte dieser Gruppe im nächsten Jahr um 6.83 % zulegen.
14 von 14 Werten dieser Gruppe werden von professionellen Analysten mit „Kaufen“ bewertet.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
Wenn Sie in diese Werte investieren:
In 12 Monaten könnte der Wert betragen:
+6.83%
